Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Artificial Skin Market Based on Need For Patient, Gelatin-Contained Artificial Skin, Composite Biocompatible Epidermal Graft), Based on distribution channel and Region Forecast 2021-2032
Artificial Skin Market size was valued at US$ 3,731.6 million in 2025 and is expected to reach US$ 6,333.4 million by 2032, growing at a significant CAGR of 7.9% from 2026-2032. Artificial skin is synthetic skin used to replace human skin to save patients from burns injuries and other skin infections. It is also known as regenerative artificial skin. Artificial skin is a collagen scaffold that induces the regeneration of the skin. It is used to treat patients with major burns, deep wounds and also used during plastic surgery. The companies also advancing the artificial skin technologies to use with robotics and maximizing the applications of artificial skin. In addition, companies are also involved in collaborations and acquisitions to expand their market share and position in the global market. For instance, in January 2018, Shiseido Company, Limited has acquired Olivo Laboratories, LLC along wot its pioneering XPL second skin technology.
Study Period
2026-2032Base Year
2025CAGR
7.9%Largest Market
North-AmericaFastest Growing Market
Europe
Global artificial skin market is driven by the increase in the number of injuries and burns worldwide. Furthermore, growing adaptation of the skin regeneration treatments in plastic surgery and rise in awareness of artificial skin products expected to boost the market growth. In addition, advancements in the artificial skin technologies such as autologous spray on skin and expansion of the applications of artificial skin into the beauty and skin care segments projected to bolster the market growth over the forecast period. However, high cost of the treatment and artificial skin products and complications such as acceptance by the body projected to hamper the market growth over the forecast period.
|
Report Benchmarks |
Details |
|
Report Study Period |
2026-2032 |
|
Market CAGR |
7.9% |
|
By Need For Patient |
|
|
By Distribution Channel |
|
|
By Region |
|
Download Free Sample Report
Artificial Skin Market size was valued at US$ 3,731.6 million in 2025 and is expected to reach US$ 6,333.4 million by 2032, growing at a significant CAGR of 7.9% from 2026-2032.
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.
Content Updated Date: Feb 2026
| 1. Executive Summary |
| 2. Global Artificial Skin Market Introduction |
| 2.1.Global Artificial Skin Market - Taxonomy |
| 2.2.Global Artificial Skin Market - Definitions |
| 2.2.1.Need For Patient |
| 2.2.2.Distribution Channel |
| 2.2.3.Region |
| 3. Global Artificial Skin Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4. Global Artificial Skin Market Analysis, 2021-2025 and Forecast 2026-2032 |
| 4.1. Market Analysis, 2021-2025 and Forecast 2026-2032, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Artificial Skin Market By Need For Patient, 2021-2025 and Forecast 2026-2032 (Sales Value USD Million) |
| 5.1. Spray-on Skin |
| 5.1.1. Market Analysis, 2021-2025 and Forecast 2026-2032, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Temporary Skin Graft |
| 5.2.1. Market Analysis, 2021-2025 and Forecast 2026-2032, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Permanent Skin Graft |
| 5.3.1. Market Analysis, 2021-2025 and Forecast 2026-2032, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Artificial Electric Skin (e-Skin) |
| 5.4.1. Market Analysis, 2021-2025 and Forecast 2026-2032, (Sales Value USD Million) |
| 5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 5.5. Gelatin-Contained Artificial Skin |
| 5.5.1. Market Analysis, 2021-2025 and Forecast 2026-2032, (Sales Value USD Million) |
| 5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.5.3. Market Opportunity Analysis |
| 5.6. Composite Biocompatible Epidermal Graft |
| 5.6.1. Market Analysis, 2021-2025 and Forecast 2026-2032, (Sales Value USD Million) |
| 5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.6.3. Market Opportunity Analysis |
| 6. Global Artificial Skin Market By Distribution Channel, 2021-2025 and Forecast 2026-2032 (Sales Value USD Million) |
| 6.1. Retail Pharmacies |
| 6.1.1. Market Analysis, 2021-2025 and Forecast 2026-2032, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Hospitals |
| 6.2.1. Market Analysis, 2021-2025 and Forecast 2026-2032, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Others |
| 6.3.1. Market Analysis, 2021-2025 and Forecast 2026-2032, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 7. Global Artificial Skin Market By Region, 2021-2025 and Forecast 2026-2032 (Sales Value USD Million) |
| 7.1. North America |
| 7.1.1. Market Analysis, 2021-2025 and Forecast 2026-2032, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Europe |
| 7.2.1. Market Analysis, 2021-2025 and Forecast 2026-2032, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Asia Pacific (APAC) |
| 7.3.1. Market Analysis, 2021-2025 and Forecast 2026-2032, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Middle East and Africa (MEA) |
| 7.4.1. Market Analysis, 2021-2025 and Forecast 2026-2032, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Latin America |
| 7.5.1. Market Analysis, 2021-2025 and Forecast 2026-2032, (Sales Value USD Million) |
| 7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 8. North America Artificial Skin Market ,2021-2025 and Forecast 2026-2032 (Sales Value USD Million) |
| 8.1. Need For Patient Analysis 2021-2025 and Forecast 2026-2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.1.1.Spray-on Skin |
| 8.1.2.Temporary Skin Graft |
| 8.1.3.Permanent Skin Graft |
| 8.1.4.Artificial Electric Skin (e-Skin) |
| 8.1.5.Gelatin-Contained Artificial Skin |
| 8.1.6.Composite Biocompatible Epidermal Graft |
| 8.2. Distribution Channel Analysis 2021-2025 and Forecast 2026-2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.2.1.Retail Pharmacies |
| 8.2.2.Hospitals |
| 8.2.3.Others |
| 8.3. Country Analysis 2021-2025 and Forecast 2026-2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.3.1.United States of America (USA) |
| 8.3.2.Canada |
| 9. Europe Artificial Skin Market ,2021-2025 and Forecast 2026-2032 (Sales Value USD Million) |
| 9.1. Need For Patient Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Spray-on Skin |
| 9.1.2.Temporary Skin Graft |
| 9.1.3.Permanent Skin Graft |
| 9.1.4.Artificial Electric Skin (e-Skin) |
| 9.1.5.Gelatin-Contained Artificial Skin |
| 9.1.6.Composite Biocompatible Epidermal Graft |
| 9.2. Distribution Channel Analysis 2021-2025 and Forecast 2026-2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Retail Pharmacies |
| 9.2.2.Hospitals |
| 9.2.3.Others |
| 9.3. Country Analysis 2021-2025 and Forecast 2026-2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Germany |
| 9.3.2.France |
| 9.3.3.Italy |
| 9.3.4.United Kingdom (UK) |
| 9.3.5.Spain |
| 9.3.6.Rest of EU |
| 10. Asia Pacific (APAC) Artificial Skin Market ,2021-2025 and Forecast 2026-2032 (Sales Value USD Million) |
| 10.1. Need For Patient Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Spray-on Skin |
| 10.1.2.Temporary Skin Graft |
| 10.1.3.Permanent Skin Graft |
| 10.1.4.Artificial Electric Skin (e-Skin) |
| 10.1.5.Gelatin-Contained Artificial Skin |
| 10.1.6.Composite Biocompatible Epidermal Graft |
| 10.2. Distribution Channel Analysis 2021-2025 and Forecast 2026-2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Retail Pharmacies |
| 10.2.2.Hospitals |
| 10.2.3.Others |
| 10.3. Country Analysis 2021-2025 and Forecast 2026-2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.China |
| 10.3.2.India |
| 10.3.3.Australia and New Zealand (ANZ) |
| 10.3.4.Japan |
| 10.3.5.Rest of APAC |
| 11. Middle East and Africa (MEA) Artificial Skin Market ,2021-2025 and Forecast 2026-2032 (Sales Value USD Million) |
| 11.1. Need For Patient Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Spray-on Skin |
| 11.1.2.Temporary Skin Graft |
| 11.1.3.Permanent Skin Graft |
| 11.1.4.Artificial Electric Skin (e-Skin) |
| 11.1.5.Gelatin-Contained Artificial Skin |
| 11.1.6.Composite Biocompatible Epidermal Graft |
| 11.2. Distribution Channel Analysis 2021-2025 and Forecast 2026-2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Retail Pharmacies |
| 11.2.2.Hospitals |
| 11.2.3.Others |
| 11.3. Country Analysis 2021-2025 and Forecast 2026-2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.GCC Countries |
| 11.3.2.South Africa |
| 11.3.3.Rest of MEA |
| 12. Latin America Artificial Skin Market ,2021-2025 and Forecast 2026-2032 (Sales Value USD Million) |
| 12.1. Need For Patient Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Spray-on Skin |
| 12.1.2.Temporary Skin Graft |
| 12.1.3.Permanent Skin Graft |
| 12.1.4.Artificial Electric Skin (e-Skin) |
| 12.1.5.Gelatin-Contained Artificial Skin |
| 12.1.6.Composite Biocompatible Epidermal Graft |
| 12.2. Distribution Channel Analysis 2021-2025 and Forecast 2026-2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Retail Pharmacies |
| 12.2.2.Hospitals |
| 12.2.3.Others |
| 12.3. Country Analysis 2021-2025 and Forecast 2026-2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Brazil |
| 12.3.2.Mexico |
| 12.3.3.Rest of LA |
| 13. Competition Landscape |
| 13.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 13.2.1.Integra Life Sciences Corporation (U.S.) |
| 13.2.2.Johnson & Johnson Services, Inc. (U.S.) |
| 13.2.3.Mylan N.V. (U.K.) |
| 13.2.4.Mallinckrodt plc (U.K) |
| 13.2.5.Smith & Nephew plc (U.K.) |
| 13.2.6.Shiseido Company, Limited (Japan) |
| 13.2.7.Greiner Group AG (Austria) |
| 14. Research Methodology |
| 15. Appendix and Abbreviations |
Key Market Players